anmeldenNASDAQ 100
29.435,97
PKT
-205,59
PKT
-0,69
%
Indikation*
29.433,43
PKT
-208,13
PKT
-0,70
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.17 | Apple Outperform | RBC Capital Markets | |
| 03.11.17 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 02.11.17 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 02.11.17 | Broadcom Buy | B. Riley FBR, Inc. | |
| 02.11.17 | Meta Platforms (ex Facebook) overweight | Morgan Stanley | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | RBC Capital Markets | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | Credit Suisse Group | |
| 02.11.17 | Meta Platforms (ex Facebook) buy | UBS AG | |
| 02.11.17 | Meta Platforms (ex Facebook) overweight | Atlantic Equities | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | Macquarie Research | |
| 02.11.17 | Meta Platforms (ex Facebook) Market Outperform | JMP Securities LLC | |
| 02.11.17 | QUALCOMM Buy | Canaccord Adams | |
| 02.11.17 | Meta Platforms (ex Facebook) overweight | JP Morgan Chase & Co. | |
| 02.11.17 | Meta Platforms (ex Facebook) buy | Needham & Company, LLC | |
| 02.11.17 | Meta Platforms (ex Facebook) buy | Stifel, Nicolaus & Co., Inc. | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | RBC Capital Markets | |
| 02.11.17 | Tesla Sector Perform | RBC Capital Markets | |
| 01.11.17 | Intel buy | Stifel, Nicolaus & Co., Inc. | |
| 01.11.17 | Intel Neutral | BNP PARIBAS | |
| 01.11.17 | Meta Platforms (ex Facebook) Buy | Aegis Capital | |
| 01.11.17 | Take Two Buy | Stifel, Nicolaus & Co., Inc. | |
| 31.10.17 | Roper Technolgies Outperform | RBC Capital Markets | |
| 30.10.17 | Linde Neutral | JP Morgan Chase & Co. | |
| 30.10.17 | Linde market-perform | Bernstein Research | |
| 30.10.17 | Linde buy | Deutsche Bank AG | |
| 30.10.17 | NVIDIA Outperform | RBC Capital Markets | |
| 30.10.17 | Alnylam Pharmaceuticals Buy | FBR & Co. | |
| 30.10.17 | Linde Hold | Warburg Research | |
| 27.10.17 | Linde Sell | S&P Capital IQ | |
| 27.10.17 | Linde Equal weight | Barclays Capital | |
| 27.10.17 | Comcast overweight | Barclays Capital | |
| 27.10.17 | Microsoft Buy | Canaccord Adams | |
| 27.10.17 | Alphabet C (ex Google) buy | Deutsche Bank AG | |
| 27.10.17 | Linde Halten | Independent Research GmbH | |
| 27.10.17 | Alphabet A (ex Google) Outperform | Macquarie Research | |
| 27.10.17 | Intel buy | Nomura | |
| 27.10.17 | Intel buy | Merrill Lynch & Co., Inc. | |
| 27.10.17 | Microsoft buy | Goldman Sachs Group Inc. | |
| 27.10.17 | Microsoft Neutral | Macquarie Research | |
| 27.10.17 | Alphabet A (ex Google) Conviction Buy List | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
